AAN Day 3: Researchers answer important questions about treatment strategies for MS
The conversations taking place on the third day at AAN shifted gears from the day before, placing the focus back on multiple sclerosis…
“You’re a diver, baby.”
Guest post by Kim Wilson, MS Walk ambassador The first time I went scuba diving was a disaster. Diving for views of the…
AAN Day 2: NMO spectrum disorder takes centre-stage for a day
One of today’s sessions placed the focus squarely on neuromyelitis optica (more recently expanded to be called neuromyelitis optica spectrum disorder, or NMOSD),…
AAN Day 1: Modeling MS-like disease and exploring risk factors
This year’s AAN conference is filled to the brim with programming, with sessions starting bright and early at 6:30 am and continuing well…
American Academy of Neurology meeting kicks off in Vancouver
This year, more than 10,000 neurologists and basic researchers from all over the world are converging on the stunningly beautiful city of Vancouver…
Growing strong communities from the roots up
Volunteers are at the root of building strong communities. This year, our theme for National Volunteer Week reminds us to celebrate the profound…
Connections, effecting change: Celebrating our volunteers
Volunteering is the ultimate expression of human connection – people acting selflessly on behalf of their communities driven by a desire to contribute…
National Volunteer Week 2016
National Volunteer Week is an opportunity for us to celebrate and express how grateful we are to the thousands of volunteers who make…
Are you there, MS?
Guest post from Chantal Milne, MS Walk ambassador I was scared when I first met you. I mean, making me numb from the…
Unwavering love, it comes with the territory
Guest post by Kirsten Mooney, MS Walk ambassador Over the years, my mother and I switched roles – I became the caregiver.…
What is MS?
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 77,000 Canadians living with the disease. While it is most often diagnosed in young adults aged 20 to 49, younger children and older adults are also diagnosed with the disease.